Aju Pharm Co Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Aju Pharm Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10830
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aju Pharm Co Ltd (Aju Pharm) is a pharma and medical device company. The company operates in the business such as pharmaceutical, CMO, medical device, global business and consumer health business. Its pharmaceutical business provides drugs for hypertension, antibiotics, and anti-inflammatory analgesics. Aju Pharm’s CMO business division offers oral solids, oral liquids, injectables and cephalosporins. The company’s medical device segment offers anchor disposable device, cannula, polyolefin infusion set, adhesive and non-adhesive wound dressings, laparoscopic and thoracoscopic trocars, wire devices and others. It collaborates with medical institutions, medical practitioners, and the academia. The company operates its offices in Suwon, Gangwon, Jeonju, Daegu, Busan, Yongin, Daejeon, Gwangju, Jeju and Gyeongnam, South Korea. Aju Pharm is headquartered in Seoul, South Korea.

Aju Pharm Co Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
SynCore Biotech Enters into Co-Development Contract with Aju Pharm 10
Licensing Agreements 11
Aju Pharm Enters into Licensing Agreement with Korea Research Institute of Bioscience and Biotechnology 11
Equity Offering 12
AntriaBio Raises USD4.5 Million in Private Placement of Shares 12
Aju Pharm Co Ltd – Key Competitors 13
Aju Pharm Co Ltd – Key Employees 14
Aju Pharm Co Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aju Pharm Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SynCore Biotech Enters into Co-Development Contract with Aju Pharm 10
Aju Pharm Enters into Licensing Agreement with Korea Research Institute of Bioscience and Biotechnology 11
AntriaBio Raises USD4.5 Million in Private Placement of Shares 12
Aju Pharm Co Ltd, Key Competitors 13
Aju Pharm Co Ltd, Key Employees 14
Aju Pharm Co Ltd, Other Locations 15

List of Figures
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Aju Pharm Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Aju Pharm Co Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Unilever Pakistan Limited:企業の戦略・SWOT・財務分析
    SummaryUnilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • TRANS GENIC, INC.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' TRANS GENIC, INC. Mergers and A …
  • ImageONE Co., Ltd. (2667):企業概要、財務及び戦略的SWOT分析
    Summary ImageONE Co., Ltd. (ImageOne) is an information technology service provider. The company provides digital image information products and services. It offers medical information and integration systems, medical image viewers, iPad/iPhone, server systems, image viewer systems, ultrasound syste …
  • Prosensa Therapeutics B.V.(製薬・医療分野):企業M&A動向
    Summary Prosensa Therapeutics B.V. (Prosensa) is a biotechnology company. The company discovers, develops and commercializes RNA modulating therapeutics. Its focus is on three Neuromuscular Disorders, namely, Duchenne Muscular Dystrophy(DMD), Myotonic Dystrophy(DM1) and Huntington’s disease(HD). Pro …
  • Level 3 Communications, Inc. (LVLT):企業の財務及び戦略的SWOT分析
    Level 3 Communications, Inc. (LVLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Landmarks Berhad:企業の戦略・SWOT・財務分析
    SummaryLandmarks Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findin …
  • Sagicor Financial Corporation:企業の戦略・SWOT・財務分析
    SummarySagicor Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …
  • First Derivatives plc (FDP):企業の財務・戦略的SWOT分析
    First Derivatives plc (FDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Dor Alon Energy In Israel (1988) Ltd. (DRAL):企業財務及び戦略的SWOT分析
    Summary Dor Alon Energy In Israel (1988) Ltd. (Dor Alon), a subsidiary of Alon Holdings Blue Square – Israel LTD is an oil and gas company that offers petroleum products. The company operates fuel station and has a chain of convenience stores integrated with the fuel stations. It provides speedomat, …
  • Bayer Healthcare Pharmaceuticals:企業の戦略・SWOT・財務情報
    Bayer Healthcare Pharmaceuticals - Strategy, SWOT and Corporate Finance Report Summary Bayer Healthcare Pharmaceuticals - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Olon SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Olon SpA (Olon), formerly Antibioticos SpA, a susbsidiary of P&R S.p.A. is a developer and producer of active pharmaceutical ingredients. The company offers products such as azacitidine, bezafibrate, ibuprofen sodium, acamprosate calcium, acebutolol hydrochloride, acitretin, thalidomide, aba …
  • CARBO Ceramics Inc. (CRR):企業の財務及び戦略的SWOT分析
    Summary CARBO Ceramics Inc. (CARBO Ceramics) is an oilfield services technology company which designs and builds optimized production enhancement solutions; engineered spill prevention and containment solutions; and environmental solutions. The company’s solutions focuses on increasing the productio …
  • Tokyo Ohka Kogyo Co., Ltd. (4186):企業概要、財務及び戦略的SWOT分析
    Summary Tokyo Ohka Kogyo Co., Ltd. (Tokyo Ohka) manufactures and markets chemical products, semiconductors and other energy products. Its products include liquid crystal displays, electronic equipment, flat-screen television sets, personal computers, cellular phones, solar cell, inorganic and organi …
  • Nippon Electric Glass Co., Ltd.:企業の戦略・SWOT・財務分析
    SummaryNippon Electric Glass Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the comp …
  • Spectrum Dynamics Medical, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Spectrum Dynamics Medical, Inc. (Spectrum Dynamics) is a medical device company. The company develops medical devices for the diagnostic imaging markets. Its cardiac imaging system is a device that offers nuclear images. Spectrum Dynamics’s products include CZT based solid state detectors, a …
  • Merro Pharmaceutical Co Ltd:企業のM&A・提携動向(医療分野)
    Summary Merro Pharmaceutical Co Ltd (Merro Pharma) is a pharmaceutical products manufacturer that discovers, develops, manufactures, sells and markets chemical medicine. The company provides biological medicine, Chinese traditional medicine and herbal medicine. Its products include amifostine, roxit …
  • Wesfarmers Limited (WES):企業のM&A・提携動向(発電分野)
    Summary Wesfarmers Limited (Wesfarmers) is a diversified company that has business operations in retail and industrial activities. Its retail activities include supermarkets, liquor, hotels and convenience stores; department stores; home improvement and office supplies; and apparel retailing. The co …
  • Moya Asia Limited (5WE):企業の戦略的SWOT分析
    Summary Moya Asia Limited (Moya), formerly Moya Dayen Limited is an integrated water and wastewater company that provides investment and development of total water solutions. The company’s products include mechanical screens, stainless steel penstock, surface aerators, sludge storage and conveyance …
  • ProteoMediX AG:製品パイプライン分析2015
    Summary ProteoMediX AG (ProteoMediX) is a diagnostic company. The company identifies and develops biomarkers for the early detection of cancer and the personalized treatment. It offers products for prostate cancer detection, prostate cancer stratification, and prostate cancer prognosis. The company’ …
  • Perilya Limited:企業の戦略・SWOT・財務分析
    SummaryPerilya Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Finding …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆